Des-gamma-carboxy prothrombin affects the survival of HCC patients with marginal liver function and curative treatment: ACRoS1402
Atsushi Kudo(Tokyo Medical and Dental University), Masakazu Yamamoto(Tokyo Women's Medical University), Yuko Kitagawa(Keio University), Takafumi Kumamoto(Yokohama City University), Itaru Endo(Yokohama City University), Takehito Otsubo(St. Marianna University School of Medicine), Masafumi Katayama(National Institute for Environmental Studies), Masahiro Shinoda(Keio University), Minoru Tanabe(Tokyo Institute of Technology), Shun‐ichi Ariizumi(Tokyo Women's Medical University)
Cited by 16
Related Papers
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k
A novel difficulty scoring system for laparoscopic liver resection
|Journal of Hepato-Biliary-Pancreatic Sciences|2014|560
Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer
|British journal of surgery|2018|401
Clinical practice guidelines for the management of biliary tract cancers 2015: the 2<sup>nd</sup> English edition
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|300
Comprehensive molecular and immunological characterization of hepatocellular carcinoma
|EBioMedicine|2018|277